Cold Spring Harbor Laboratory Professor Douglas Fearon discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy...
Vous n'êtes pas connecté
Scientists at the Leibniz Institute for Immunotherapy in Germany have discovered that the LMO4 gene can enhance the stemness of T cells, increasing their effectiveness in fighting cancer. Research results It was published In the journal Signal Transduction and Targeted Therapy (STTT). Scientists conducted a series of experiments on laboratory mice and human cell cultures […]
Cold Spring Harbor Laboratory Professor Douglas Fearon discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy...
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...
Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease. A new...
Scientists at the University of Southampton have uncovered how the immune system's natural killer cells can target a protein known as XPO1, which...
American scientists from the Cold Spring Harbor Laboratory in New York have discovered a method that allows cancer cells to be deprived of nutrients...
A recent study by Ludwig Cancer Research has uncovered a crucial metabolic switch in the immune system’s T cells that plays a vital role in creating...
Immune checkpoint inhibitors are cancer-fighting drugs that help the immune system do its job of detecting and attacking tumour cells. Programmed Cell...
It comes after research led by the University of Southampton.
Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer.
A recent study by scientists at the Garvan Institute of Medical Research has uncovered a surprising connection between certain gene variants...